CWF19L1
protein-codingCWF19 like cell cycle control factor 1, the group of Small nucleolar RNA protein coding host genes
Gene summary
This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0015244
Submitter: ClinGen
*CWF19L1* was first reported in relation to autosomal recessive spinocerebellar ataxia in 2014 (Burns R, et al., PMID: 25361784). The *CWF19L1* gene is thought to play a role in cell cycle control, endosomal trafficking and mRNA processing (PMID: 36357319). Autosomal recessive cerebellar ataxia due to variants in *CWF19L1* is characterized by gait, limb, and truncal ataxia, developmental delay, hypotonia, intellectual disability, and cerebellar atrophy or hypoplasia on brain imaging. Other features may be present as well and patients typically, but not always, have an early age of onset (PMID: 36453471). Fourteen variants (4 canonical splice-site, 5 missense, 2 frameshift, 2 nonsense, 1 in-frame deletion) that have been reported in 12 probands in 9 publications (PMIDs: 25361784, 26197978, 27016154, 38681507, 36357319, 36530930, 36453471, 37752213, 33012273) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by a morpholino-mediated knockdown of *CWF19L1* in zebrafish that led to cerebellar and movement abnormalities (PMID: 25361784). In summary, there is definitive evidence supporting the relationship between *CWF19L1* and autosomal recessive spinocerebellar ataxia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Ataxia GCEP on the meeting date May 14, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014503
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014503
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014503
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014503
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CWF19L1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018294.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 15 | |||
| missense | 1 | 4 | 85 | 9 | 1 | 100 |
| nonsense | 5 | 7 | 1 | 13 | ||
| start loss | 0 | |||||
| frameshift | 2 | 7 | 9 | |||
| splice donor/acceptor (+/-2bp) | 4 | 5 | 3 | 12 | ||
| Total | 12 | 23 | 90 | 23 | 1 | 149 |
Highest pathogenic variant AF is 0.00008208261
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060764.3 | 14 | MANE Select | |
| Ensembl | ENSP00000326411.6 | 14 | MANE Select | |
| RefSeq | NP_001290333.1 | 13 | Standard | |
| RefSeq | NP_001290334.1 | 10 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cwf19l1 | Danio rerio | Structure: cerebellum Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- biological_process
Molecular Function
- molecular_function
Cellular Component
- cellular_component
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000354105
- Coding exons
- 14
- Length
- 35383
- Individuals with no LoFs
- 125610
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 137
- Defined
- 125747
- p
- 0.000545
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.10 | 232 | 284 | 0.817 | 0.0000140 | 3529 |
| Missense (PolyPhen) | 64 | 79.96 | 0.8004 | 961 | ||
| Synonymous | 1.01 | 88 | 101 | 0.872 | 0.00000490 | 998 |
| Loss of Function | 0.887 | 26 | 31.4 | 0.829 | 0.00000156 | 382 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00080 | 0.00080 | rare |
| Latino/Admixed American | 0.00036 | 0.00035 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0.0014 | 0.0014 | notable |
| European (Non-Finnish) | 0.00043 | 0.00043 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0825
Intolerance Scores
- LoFtool
- 0.901
- RVIS EVS
- 0.46
- RVIS percentile EVS
- 78.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Indispensability pred.
- N
- Indispensability score
- 0.00112
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |